Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2

Epidemiological and mechanistic studies suggest that some US Food and Drug Administration (FDA)-approved drugs can reduce the incidence of cancer and inhibit tumor growth. Therefore, investigating FDA-approved drugs for cancer chemoprevention is a promising strategy. In this study, we screened FDA-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lili, Zhang, Yuhan, Li, Ang, Lu, Xuebo, Li, Mingzhu, Yuan, Qiang, Yang, Ning, Zhao, Xiaokun, Li, Xin, Jiang, Yanan, Liu, Kangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574346/
https://www.ncbi.nlm.nih.gov/pubmed/36284716
http://dx.doi.org/10.1016/j.omto.2022.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574346/
https://www.ncbi.nlm.nih.gov/pubmed/36284716
http://dx.doi.org/10.1016/j.omto.2022.09.007

Ejemplares similares